Search research articles
Contact Us
Filters
Showing results (771-780 of 1,192) with videos related to
Page
of 120
Sort By:
American Journal of Hematology
|
February 18, 2011
Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis
Shaji K Kumar, Angela Dispenzieri, Martha Q Lacy, et al.
The American Journal of Gastroenterology
|
February 11, 2015
Trends and racial/ethnic disparities in gluten-sensitive problems in the United States: findings from the National Health and Nutrition Examination Surveys from 1988 to 2012
Rok Seon Choung, Ivo C Ditah, Ashley M Nadeau, et al.
The British Journal of Dermatology
|
September 18, 2010
The role of stem cell factor and c-KIT in keloid pathogenesis: do tyrosine kinase inhibitors have a potential therapeutic role?
A Mukhopadhyay, D V Do, C T Ong, et al.
Blood Cancer Journal
|
March 29, 2025
Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis
Sharlene Dong, Rahul Banerjee, Adeel M Khan, et al.
Mucosal Immunology
|
November 5, 2015
The respiratory DC/macrophage network at steady-state and upon influenza infection in the swine biomedical model
P Maisonnasse, E Bouguyon, G Piton, et al.
Addiction Biology
|
November 19, 2024
Increased white blood cell in young adults with family histories of alcohol and other substance use disorders
Mustafa N Mithaiwala, Nikki S Phillips, Dylan H Nguyen, et al.
Sleep
|
October 2, 2012
Learning to live on a Mars day: fatigue countermeasures during the Phoenix Mars Lander mission
Laura K Barger, Jason P Sullivan, Andrea S Vincent, et al.
Blood
|
April 28, 2010
Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women
Ola Landgren, S Vincent Rajkumar, Ruth M Pfeiffer, et al.
Lancet (London, England)
|
December 27, 2016
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial
Brian G M Durie, Antje Hoering, Muneer H Abidi, et al.
Mayo Clinic Proceedings
|
July 13, 2004
Clinical course of patients with relapsed multiple myeloma
Shaji K Kumar, Terry M Therneau, Morie A Gertz, et al.
Page
of 120
Search research articles
Search
Showing results (771-780 of 1,192) with videos related to
Sort By:
Page
of 120
American Journal of Hematology
|
February 18, 2011
Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis
Shaji K Kumar, Angela Dispenzieri, Martha Q Lacy, et al.
The American Journal of Gastroenterology
|
February 11, 2015
Trends and racial/ethnic disparities in gluten-sensitive problems in the United States: findings from the National Health and Nutrition Examination Surveys from 1988 to 2012
Rok Seon Choung, Ivo C Ditah, Ashley M Nadeau, et al.
The British Journal of Dermatology
|
September 18, 2010
The role of stem cell factor and c-KIT in keloid pathogenesis: do tyrosine kinase inhibitors have a potential therapeutic role?
A Mukhopadhyay, D V Do, C T Ong, et al.
Blood Cancer Journal
|
March 29, 2025
Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis
Sharlene Dong, Rahul Banerjee, Adeel M Khan, et al.
Mucosal Immunology
|
November 5, 2015
The respiratory DC/macrophage network at steady-state and upon influenza infection in the swine biomedical model
P Maisonnasse, E Bouguyon, G Piton, et al.
Addiction Biology
|
November 19, 2024
Increased white blood cell in young adults with family histories of alcohol and other substance use disorders
Mustafa N Mithaiwala, Nikki S Phillips, Dylan H Nguyen, et al.
Sleep
|
October 2, 2012
Learning to live on a Mars day: fatigue countermeasures during the Phoenix Mars Lander mission
Laura K Barger, Jason P Sullivan, Andrea S Vincent, et al.
Blood
|
April 28, 2010
Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women
Ola Landgren, S Vincent Rajkumar, Ruth M Pfeiffer, et al.
Lancet (London, England)
|
December 27, 2016
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial
Brian G M Durie, Antje Hoering, Muneer H Abidi, et al.
Mayo Clinic Proceedings
|
July 13, 2004
Clinical course of patients with relapsed multiple myeloma
Shaji K Kumar, Terry M Therneau, Morie A Gertz, et al.
Page
of 120